BROOKE MORRIS: Open Payments
NPI 1548906514 · DICKINSON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 19 payments from 11 companies in 2025. Trend: 2023 $669 · 2024 $426 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Amgen Inc. | 5 | $75 |
| Verona Pharma, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CAPLYTA, OTEZLA, Ohtuvayre, EVENITY, ELIQUIS, VYNDAQEL, INGREZZA, Dexcom G6 Transmitter.
Industry payments across ND — which companies pay providers there.
